Announced
Completed
Financials
Sources
Tags
Pharmaceuticals
Domestic
Single Bidder
Private
Majority
injectable pharmaceuticals
Acquisition
Completed
Canada
Friendly
Synopsis
Juno Pharmaceuticals, a biopharmaceutical company, completed the acquisition of Omega Laboratories, a domestic specialty injectable pharmaceutical manufacturer. Financial terms were not disclosed. “We are proud of this acquisition that solidifies Juno’s ability to improve drug supply with medications that are critically needed to support our healthcare system. We are Canadian owned and operated and will continue to support our domestic market while expanding into new geographies with dependable and high-quality Canadian-made pharmaceuticals,” Mark Mantel, Juno CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.